Logo image of CGNX

COGNEX CORP (CGNX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CGNX - US1924221039 - Common Stock

39.43 USD
+0.42 (+1.08%)
Last: 1/12/2026, 8:00:00 PM
39.81 USD
+0.38 (+0.96%)
Pre-Market: 1/13/2026, 8:01:04 AM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to CGNX. CGNX was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. CGNX has an excellent financial health rating, but there are some minor concerns on its profitability. CGNX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CGNX was profitable.
In the past year CGNX had a positive cash flow from operations.
CGNX had positive earnings in each of the past 5 years.
CGNX had a positive operating cash flow in each of the past 5 years.
CGNX Yearly Net Income VS EBIT VS OCF VS FCFCGNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

CGNX's Return On Assets of 5.50% is fine compared to the rest of the industry. CGNX outperforms 73.60% of its industry peers.
CGNX has a better Return On Equity (7.39%) than 64.80% of its industry peers.
CGNX's Return On Invested Capital of 7.09% is fine compared to the rest of the industry. CGNX outperforms 72.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CGNX is in line with the industry average of 8.82%.
Industry RankSector Rank
ROA 5.5%
ROE 7.39%
ROIC 7.09%
ROA(3y)7.31%
ROA(5y)9.14%
ROE(3y)9.83%
ROE(5y)12.61%
ROIC(3y)7.69%
ROIC(5y)9.5%
CGNX Yearly ROA, ROE, ROICCGNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of CGNX (11.33%) is better than 88.00% of its industry peers.
In the last couple of years the Profit Margin of CGNX has declined.
CGNX's Operating Margin of 16.27% is amongst the best of the industry. CGNX outperforms 90.40% of its industry peers.
In the last couple of years the Operating Margin of CGNX has declined.
The Gross Margin of CGNX (67.65%) is better than 96.80% of its industry peers.
In the last couple of years the Gross Margin of CGNX has declined.
Industry RankSector Rank
OM 16.27%
PM (TTM) 11.33%
GM 67.65%
OM growth 3Y-25.46%
OM growth 5Y-8.53%
PM growth 3Y-24.51%
PM growth 5Y-16.2%
GM growth 3Y-2.25%
GM growth 5Y-1.51%
CGNX Yearly Profit, Operating, Gross MarginsCGNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

CGNX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CGNX has less shares outstanding than it did 1 year ago.
CGNX has less shares outstanding than it did 5 years ago.
There is no outstanding debt for CGNX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CGNX Yearly Shares OutstandingCGNX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CGNX Yearly Total Debt VS Total AssetsCGNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 9.06 indicates that CGNX is not in any danger for bankruptcy at the moment.
CGNX has a better Altman-Z score (9.06) than 83.20% of its industry peers.
There is no outstanding debt for CGNX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.06
ROIC/WACC0.75
WACC9.42%
CGNX Yearly LT Debt VS Equity VS FCFCGNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CGNX has a Current Ratio of 3.96. This indicates that CGNX is financially healthy and has no problem in meeting its short term obligations.
CGNX has a better Current ratio (3.96) than 72.80% of its industry peers.
CGNX has a Quick Ratio of 3.11. This indicates that CGNX is financially healthy and has no problem in meeting its short term obligations.
CGNX has a Quick ratio of 3.11. This is in the better half of the industry: CGNX outperforms 75.20% of its industry peers.
Industry RankSector Rank
Current Ratio 3.96
Quick Ratio 3.11
CGNX Yearly Current Assets VS Current LiabilitesCGNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

CGNX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.62%, which is quite impressive.
CGNX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.03% yearly.
Looking at the last year, CGNX shows a quite strong growth in Revenue. The Revenue has grown by 10.23% in the last year.
The Revenue has been growing slightly by 4.74% on average over the past years.
EPS 1Y (TTM)44.62%
EPS 3Y-20.81%
EPS 5Y-2.03%
EPS Q2Q%65%
Revenue 1Y (TTM)10.23%
Revenue growth 3Y-4.11%
Revenue growth 5Y4.74%
Sales Q2Q%17.96%

3.2 Future

Based on estimates for the next years, CGNX will show a very strong growth in Earnings Per Share. The EPS will grow by 30.44% on average per year.
The Revenue is expected to grow by 9.52% on average over the next years. This is quite good.
EPS Next Y32.68%
EPS Next 2Y25.58%
EPS Next 3Y23.23%
EPS Next 5Y30.44%
Revenue Next Year8.38%
Revenue Next 2Y7.73%
Revenue Next 3Y8.05%
Revenue Next 5Y9.52%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGNX Yearly Revenue VS EstimatesCGNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B
CGNX Yearly EPS VS EstimatesCGNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 41.95, the valuation of CGNX can be described as expensive.
CGNX's Price/Earnings is on the same level as the industry average.
CGNX is valuated expensively when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.
CGNX is valuated quite expensively with a Price/Forward Earnings ratio of 33.79.
CGNX's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of CGNX to the average of the S&P500 Index (23.98), we can say CGNX is valued slightly more expensively.
Industry RankSector Rank
PE 41.95
Fwd PE 33.79
CGNX Price Earnings VS Forward Price EarningsCGNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

CGNX's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, CGNX is valued a bit cheaper than 67.20% of the companies in the same industry.
Industry RankSector Rank
P/FCF 30.91
EV/EBITDA 32.82
CGNX Per share dataCGNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

CGNX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CGNX may justify a higher PE ratio.
CGNX's earnings are expected to grow with 23.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.28
PEG (5Y)N/A
EPS Next 2Y25.58%
EPS Next 3Y23.23%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.90%, CGNX is not a good candidate for dividend investing.
CGNX's Dividend Yield is rather good when compared to the industry average which is at 0.47. CGNX pays more dividend than 84.80% of the companies in the same industry.
With a Dividend Yield of 0.90, CGNX pays less dividend than the S&P500 average, which is at 1.92.
Industry RankSector Rank
Dividend Yield 0.9%

5.2 History

The dividend of CGNX is nicely growing with an annual growth rate of 8.39%!
CGNX has paid a dividend for at least 10 years, which is a reliable track record.
CGNX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)8.39%
Div Incr Years3
Div Non Decr Years3
CGNX Yearly Dividends per shareCGNX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

CGNX pays out 49.16% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of CGNX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.16%
EPS Next 2Y25.58%
EPS Next 3Y23.23%
CGNX Yearly Income VS Free CF VS DividendCGNX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CGNX Dividend Payout.CGNX Dividend Payout, showing the Payout Ratio.CGNX Dividend Payout.PayoutRetained Earnings

COGNEX CORP

NASDAQ:CGNX (1/12/2026, 8:00:00 PM)

Premarket: 39.81 +0.38 (+0.96%)

39.43

+0.42 (+1.08%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners104.09%
Inst Owner Change0.13%
Ins Owners0.27%
Ins Owner Change-0.03%
Market Cap6.61B
Revenue(TTM)971.71M
Net Income(TTM)110.12M
Analysts76.55
Price Target48.77 (23.69%)
Short Float %3.35%
Short Ratio2.98
Dividend
Industry RankSector Rank
Dividend Yield 0.9%
Yearly Dividend0.31
Dividend Growth(5Y)8.39%
DP49.16%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.79%
Min EPS beat(2)3.71%
Max EPS beat(2)11.87%
EPS beat(4)4
Avg EPS beat(4)15.13%
Min EPS beat(4)3.71%
Max EPS beat(4)26.05%
EPS beat(8)8
Avg EPS beat(8)16.02%
EPS beat(12)11
Avg EPS beat(12)15.02%
EPS beat(16)14
Avg EPS beat(16)16.54%
Revenue beat(2)1
Avg Revenue beat(2)1.36%
Min Revenue beat(2)-0.78%
Max Revenue beat(2)3.51%
Revenue beat(4)2
Avg Revenue beat(4)1.05%
Min Revenue beat(4)-0.78%
Max Revenue beat(4)3.51%
Revenue beat(8)4
Avg Revenue beat(8)0.74%
Revenue beat(12)6
Avg Revenue beat(12)0.39%
Revenue beat(16)9
Avg Revenue beat(16)0.94%
PT rev (1m)0.53%
PT rev (3m)2.67%
EPS NQ rev (1m)1.14%
EPS NQ rev (3m)1.34%
EPS NY rev (1m)0.23%
EPS NY rev (3m)4.99%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)0.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.55%
Valuation
Industry RankSector Rank
PE 41.95
Fwd PE 33.79
P/S 6.8
P/FCF 30.91
P/OCF 29.77
P/B 4.44
P/tB 6.54
EV/EBITDA 32.82
EPS(TTM)0.94
EY2.38%
EPS(NY)1.17
Fwd EY2.96%
FCF(TTM)1.28
FCFY3.24%
OCF(TTM)1.32
OCFY3.36%
SpS5.8
BVpS8.89
TBVpS6.03
PEG (NY)1.28
PEG (5Y)N/A
Graham Number13.71
Profitability
Industry RankSector Rank
ROA 5.5%
ROE 7.39%
ROCE 8.62%
ROIC 7.09%
ROICexc 8.48%
ROICexgc 12.33%
OM 16.27%
PM (TTM) 11.33%
GM 67.65%
FCFM 22%
ROA(3y)7.31%
ROA(5y)9.14%
ROE(3y)9.83%
ROE(5y)12.61%
ROIC(3y)7.69%
ROIC(5y)9.5%
ROICexc(3y)9.56%
ROICexc(5y)11.82%
ROICexgc(3y)12.73%
ROICexgc(5y)15.09%
ROCE(3y)9.35%
ROCE(5y)11.55%
ROICexgc growth 3Y-25.69%
ROICexgc growth 5Y-4.75%
ROICexc growth 3Y-29.85%
ROICexc growth 5Y-7.09%
OM growth 3Y-25.46%
OM growth 5Y-8.53%
PM growth 3Y-24.51%
PM growth 5Y-16.2%
GM growth 3Y-2.25%
GM growth 5Y-1.51%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 26.24%
Cap/Sales 0.85%
Interest Coverage 250
Cash Conversion 117.19%
Profit Quality 194.14%
Current Ratio 3.96
Quick Ratio 3.11
Altman-Z 9.06
F-Score8
WACC9.42%
ROIC/WACC0.75
Cap/Depr(3y)84%
Cap/Depr(5y)75.71%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.9%
Profit Quality(3y)103.13%
Profit Quality(5y)109.22%
High Growth Momentum
Growth
EPS 1Y (TTM)44.62%
EPS 3Y-20.81%
EPS 5Y-2.03%
EPS Q2Q%65%
EPS Next Y32.68%
EPS Next 2Y25.58%
EPS Next 3Y23.23%
EPS Next 5Y30.44%
Revenue 1Y (TTM)10.23%
Revenue growth 3Y-4.11%
Revenue growth 5Y4.74%
Sales Q2Q%17.96%
Revenue Next Year8.38%
Revenue Next 2Y7.73%
Revenue Next 3Y8.05%
Revenue Next 5Y9.52%
EBIT growth 1Y67.86%
EBIT growth 3Y-28.52%
EBIT growth 5Y-4.2%
EBIT Next Year61.16%
EBIT Next 3Y31.29%
EBIT Next 5Y22.1%
FCF growth 1Y47.96%
FCF growth 3Y-23.43%
FCF growth 5Y-10.36%
OCF growth 1Y34.8%
OCF growth 3Y-22%
OCF growth 5Y-10.06%

COGNEX CORP / CGNX FAQ

What is the fundamental rating for CGNX stock?

ChartMill assigns a fundamental rating of 7 / 10 to CGNX.


What is the valuation status for CGNX stock?

ChartMill assigns a valuation rating of 4 / 10 to COGNEX CORP (CGNX). This can be considered as Fairly Valued.


What is the profitability of CGNX stock?

COGNEX CORP (CGNX) has a profitability rating of 6 / 10.


What is the financial health of COGNEX CORP (CGNX) stock?

The financial health rating of COGNEX CORP (CGNX) is 9 / 10.


How sustainable is the dividend of COGNEX CORP (CGNX) stock?

The dividend rating of COGNEX CORP (CGNX) is 5 / 10 and the dividend payout ratio is 49.16%.